definiens: shall mean : ( i ) [COMPANY] 's patent rights and know - how relating to protein or peptide agents or peptodomimetics, derivatives or analogs thereof, designed to target a pharmaceutically active agent to a certain site or sites in the body ( targeting technology ) ; ( ii ) [ EPIL 's patent rigbts and know - bow reiating to EPIL 's bioadhesive technology, which includes bioadhesive nanoparticuiate compositions incorporating EPIL 's Nanocrystal ® Technology, metbods of making sucb compositions, and application of such compositions to any biological surface of a plant or animal, such as mucous membranes, skin, hair, plant tissue, etc ., including but not limited to EPIL 's patent rigbts and know - bow described and claimed in US Patent Application No . 09/414,159, filed on October 8, 1999, for ; and ) ( iii ) for the avoidance of doubt, inventions, patents and know - how owned, licensed or controlled by Axogen Limited and Neurelab Limited and by all Affiliates or subsidiaries ( present or future ) of [COMPANY] Corporation, Pic . within the division of [COMPANY] Corporation, Pic carrying on business as [COMPANY] Pharmaceuticals which incorporates, inter alia, EPIL ( only to the extent that it is the owner of patents, know - how or other intellectual property or technology invented and/or developed within the division of [COMPANY] Corporation, Pic carrying on business as [COMPANY] Pharmaceuticals but, for the avoidance of doubt, not to the extent that it is the owner of patents, know­how or other intellectual property or technology expressly licensed or sub­licensed to [COMPANY] pursuant to the [COMPANY] License Agreement ), Targon 8 t I ! t i ' ~, . ' I I : r, l I I CONFIDENTIAL TREATMENT REQUESTED Corporation, Athena Neurosciences, Inc., [COMPANY] Pharmaceutical s, Inc., [COMPANY] Diagnostics, Camrick Laboratories, and [COMPANY] Europe Limited